Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40,636 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC).
Muley T, Rolny V, He Y, Wehnl B, Escherich A, Warth A, Stolp C, Schneider MA, Dienemann H, Meister M, Herth FJ, Dayyani F. Muley T, et al. Among authors: he y. Lung Cancer. 2018 Jun;120:46-53. doi: 10.1016/j.lungcan.2018.03.015. Epub 2018 Mar 17. Lung Cancer. 2018. PMID: 29748014 Free article.
Potential for the blood-based biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymal protein 4 (HE4) to detect recurrence during monitoring after surgical resection of adenocarcinoma of the lung.
Muley T, He Y, Rolny V, Wehnl B, Escherich A, Warth A, Stolp C, Schneider MA, Meister M, Herth FJ, Dayyani F. Muley T, et al. Among authors: he y. Lung Cancer. 2019 Apr;130:194-200. doi: 10.1016/j.lungcan.2019.02.017. Epub 2019 Feb 19. Lung Cancer. 2019. PMID: 30885344 Free article.
A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood test.
Muley T, Zhang X, Holdenrieder S, Korse CM, Zhi XY, Molina R, Liu Z, Hartmann G, van den Heuvel MM, Qian K, Marrades R, Engel C, He Y, Wehnl B, Dayyani F, Herth F. Muley T, et al. Among authors: he y. Tumour Biol. 2020 Sep;42(9):1010428320958603. doi: 10.1177/1010428320958603. Tumour Biol. 2020. PMID: 32964798 Free article.
Evaluation of the Elecsys® anti-Müllerian hormone assay for the prediction of hyper-response to controlled ovarian stimulation with a gonadotrophin-releasing hormone antagonist protocol.
Anckaert E, Denk B, He Y, Torrance HL, Broekmans F, Hund M. Anckaert E, et al. Among authors: he y. Eur J Obstet Gynecol Reprod Biol. 2019 May;236:133-138. doi: 10.1016/j.ejogrb.2019.02.022. Epub 2019 Mar 2. Eur J Obstet Gynecol Reprod Biol. 2019. PMID: 30909009 Free article.
Serum Anti-Müllerian Hormone Is Significantly Altered by Downregulation With Daily Gonadotropin-Releasing Hormone Agonist: A Prospective Cohort Study.
Drakopoulos P, van de Vijver A, Parra J, Anckaert E, Schiettecatte J, Blockeel C, Hund M, Verhagen-Kamerbeek WDJ, He Y, Tournaye H, Polyzos NP. Drakopoulos P, et al. Among authors: he y. Front Endocrinol (Lausanne). 2019 Feb 26;10:115. doi: 10.3389/fendo.2019.00115. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 30863367 Free PMC article.
40,636 results
You have reached the last available page of results. Please see the User Guide for more information.